Tags

Type your tag names separated by a space and hit enter

[The use of mexidol in psychiatric practice].
Zh Nevrol Psikhiatr Im S S Korsakova. 2006; 106(6):38-41.ZN

Abstract

Mexidol has been used in combination with basic therapy in 65 patients with mental disorders of organic genesis. The patients were treated during 56 days in accordance with a special scheme including the drug intake and intramuscular and intravenous injections. Mexidol exerted a positive effect on affective sphere, normalized the sleep-wake cycle, promoted rehabilitation of cognitive function thus improving the global clinical state of patients. Marked and significant improvement was found in 40,0% and 33,8% of cases, respectively. No severe side-effects were noticed.

Authors

Kosenko VG
No affiliation info available
Karagezian EA
No affiliation info available
Luneva LV
No affiliation info available
Smolenko LF
No affiliation info available

MeSH

AdolescentAdultAgedAntioxidantsCognitionDrug Administration RoutesFemaleFollow-Up StudiesHumansMental DisordersMiddle AgedPicolinesSleepTreatment Outcome

Pub Type(s)

Comparative Study
Journal Article

Language

rus

PubMed ID

16841482

Citation

Kosenko, V G., et al. "[The Use of Mexidol in Psychiatric Practice]." Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova, vol. 106, no. 6, 2006, pp. 38-41.
Kosenko VG, Karagezian EA, Luneva LV, et al. [The use of mexidol in psychiatric practice]. Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(6):38-41.
Kosenko, V. G., Karagezian, E. A., Luneva, L. V., & Smolenko, L. F. (2006). [The use of mexidol in psychiatric practice]. Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova, 106(6), 38-41.
Kosenko VG, et al. [The Use of Mexidol in Psychiatric Practice]. Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(6):38-41. PubMed PMID: 16841482.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [The use of mexidol in psychiatric practice]. AU - Kosenko,V G, AU - Karagezian,E A, AU - Luneva,L V, AU - Smolenko,L F, PY - 2006/7/18/pubmed PY - 2006/8/9/medline PY - 2006/7/18/entrez SP - 38 EP - 41 JF - Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova JO - Zh Nevrol Psikhiatr Im S S Korsakova VL - 106 IS - 6 N2 - Mexidol has been used in combination with basic therapy in 65 patients with mental disorders of organic genesis. The patients were treated during 56 days in accordance with a special scheme including the drug intake and intramuscular and intravenous injections. Mexidol exerted a positive effect on affective sphere, normalized the sleep-wake cycle, promoted rehabilitation of cognitive function thus improving the global clinical state of patients. Marked and significant improvement was found in 40,0% and 33,8% of cases, respectively. No severe side-effects were noticed. SN - 1997-7298 UR - https://www.unboundmedicine.com/medline/citation/16841482/ L2 - https://medlineplus.gov/childmentalhealth.html DB - PRIME DP - Unbound Medicine ER -

Related Citations

    More

    Others Viewed